Retinal deimination and PAD2 levels in retinas from donors with age-related macular degeneration (AMD)

Experimental Eye Research

Volumn 111, Issue , 2013, Pages 71-78

  Bonilha, Vera L ^a   Shadrach, Karen G ^a   Rayborn, Mary E ^a   Li, Yong ^a,c   Pauer, Gayle J T ^a   Hagstrom, Stephanie A ^a   Bhattacharya, Sanjoy K ^b   Hollyfield, Joe G ^a  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

AMD; Immunohistochemistry; Posttranslational modifications; Protein deimination; Retina; Retinal pigment epithelium

Indexed keywords

CITRULLINE; PROTEIN ARGININE DEIMINASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEIMINATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; ORGAN DONOR; PATHOGENESIS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; RETINA; RETINA GANGLION CELL; RETINA INNER PLEXIFORM LAYER; RETINA MACULA AGE RELATED DEGENERATION; RETINA OUTER NUCLEAR LAYER; RETINAL INNER NUCLEAR LAYER; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CITRULLINE; EYE BANKS; FEMALE; HUMANS; HYDROLASES; IMMUNOHISTOCHEMISTRY; MACULAR DEGENERATION; MALE; MIDDLE AGED; PROTEIN PROCESSING, POST-TRANSLATIONAL; RETINA; RETINAL PIGMENT EPITHELIUM;

EID: 84876732727     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2013.03.017     Document Type: Article

References (50)

1. Acharya N.K., Nagele E.P., Han M., Coretti N.J., DeMarshall C., Kosciuk M.C., Boulos P.A., Nagele R.G. Neuronal PAD4 expression and protein citrullination: possible role in production of autoantibodies associated with neurodegenerative disease. J.Autoimmun. 2012, 38:369-380.
2. Asaga H., Ishigami A. Protein deimination in the rat brain after kainate administration: citrulline-containing proteins as a novel marker of neurodegeneration. Neurosci. Lett. 2001, 299:5-8.
3. Asaga H., Akiyama K., Ohsawa T., Ishigami A. Increased and type II-specific expression of peptidylarginine deiminase in activated microglia but not hyperplastic astrocytes following kainic acid-evoked neurodegeneration in the rat brain. Neurosci. Lett. 2002, 326:129-132.
4. Beatty S., Koh H., Phil M., Henson D., Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol. 2000, 45:115-134.
5. Bando H., Shadrach K.G., Rayborn M.E., Crabb J.W., Hollyfield J.G. Clathrin and adaptin accumulation in drusen, Bruch's membrane and choroid in AMD and non-AMD donor eyes. Exp. Eye Res. 2007, 84:135-142.
6. Bhattacharya S.K., Bhat M.B., Takahara H. Modulation of peptidyl arginine deiminase 2 and implication for neurodegeneration. Curr. Eye Res. 2006, 31:1063-1071.
7. Bhattacharya S.K., Crabb J.S., Bonilha V.L., Gu X., Takahara H., Crabb J.W. Proteomics implicates peptidyl arginine deiminase 2 and optic nerve citrullination in glaucoma pathogenesis. Invest. Ophthalmol. Vis. Sci. 2006, 47:2508-2514.
8. Bhattacharya S.K., Sinicrope B., Rayborn M.E., Hollyfield J.G., Bonilha V.L. Age-related reduction in retinal deimination levels in the F344BN rat. Aging Cell 2008, 7:441-444.
9. Bhattacharya S.K. Retinal deimination in aging and disease. IUBMB Life 2009, 61:504-509.
10. Biarnés M., Monés J., Alonso J., Arias L. Update on geographic atrophy in age-related macular degeneration. Optom. Vis. Sci. 2011, 88:881-889.
11. Bonilha V.L., Rayborn M.E., Shadrach K.G., Li Y., Lundwall A., Malm J., Hollyfield J.G. Semenogelins in the human retina: differences in distribution and content between AMD and normal donor tissues. Exp. Eye Res. 2008, 86:150-156.
12. Bressler N.M., Frost L.A., Bressler S.B., Murphy R.P., Fine S.L. Natural course of poorly defined choroidal neovascularization associated with macular degeneration. Arch. Ophthalmol. 1988, 106:1537-1542.
13. Cafaro T.A., Santo S., Robles L.A., Crim N., Urrets-Zavalia J.A., Serra H.M. Peptidylarginine deiminase type 2 is over expressed in the glaucomatous optic nerve. Mol. Vis. 2010, 16:1654-1658.
14. Chen Y., Bedell M., Zhang K. Age-related macular degeneration: genetic and environmental factors of disease. Mol. Interv. 2010, 10:271-281.
15. Chen Y., Okano K., Maeda T., Chauhan V., Golczak M., Maeda A., Palczewski K. Mechanism of all-trans-retinal toxicity with implications for stargardt disease and age-related macular degeneration. J.Biol. Chem. 2012, 287:5059-5069.
16. Chen Y., Zeng J., Zhao C., Wang K., Trood E., Buehler J., Weed M., Kasuga D., Bernstein P.S., Hughes G., Fu V., Chin J., Lee C., Crocker M., Bedell M., Salasar F., Yang Z., Goldbaum M., Ferreyra H., Freeman W.R., Kozak I., Zhang K. Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors. Arch. Ophthalmol. 2011, 129:344-351.
17. Chou S.M., Wang H.S., Taniguchi A. Role of SOD-1 and nitric oxide/cyclic GMP cascade on neurofilament aggregation in ALS/MND. J.Neurol. Sci. 1996, 139(Suppl.):16-26.
18. Choudhury F., Varma R., McKean-Cowdin R., Klein R., Azen S.P. Risk factors for four-year incidence and progression of age-related macular degeneration: the los angeles latino eye study. Am. J. Ophthalmol. 2011, 152:385-395.
19. Enrique-Algeciras M., Ding D., Mastronardi F.G., Marc R.E., Porciatti V., Bhattacharya S.K. Deimination restores inner retinal visual function in a demyelinating disease. J. Clin. Inv. 2013, 123(2):646-656.
20. Ethen C.M., Reilly C., Feng X., Olsen T.W., Ferrington D.A. The proteome of central and peripheral retina with progression of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2006, 47:2280-2290.
21. Ethen C.M., Hussong S.A., Reilly C., Feng X., Olsen T.W., Ferrington D.A. Transformation of the proteasome with age-related macular degeneration. FEBS Lett. 2007, 581:885-890.
22. Freund K.B., Zweifel S.A., Engelbert M. Do we need a new classification for choroidal neovascularization in age-related macular degeneration?. Retina 2010, 30:1333-1349.
23. Giles J.T., Fert-Bober J., Park J.K., Bingham C.O., Andrade F., Fox-Talbot K., Pappas D., Rosen A., van Eyk J., Bathon J.M., Halushka M.K. Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study. Arthritis Res. Ther. 2012, 14:R39.
24. Gyorgy B., Toth E., Tarcsa E., Falus A., Buzas E.I. Citrullination: a posttranslational modification in health and disease. Int. J. Biochem. Cell. Biol. 2006, 38:1662-1677.
25. Harris M.L., Darrah E., Lam G.K., Bartlett S.J., Giles J.T., Grant A.V., Gao P., Scott W.W., El-Gabalawy H., Casciola-Rosen L., Barnes K.C., Bathon J.M., Rosen A. Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis. Arthritis Rheum. 2008, 58:1958-1967.
26. Ishigami A., Ohsawa T., Hiratsuka M., Taguchi H., Kobayashi S., Saito Y., Murayama S., Asaga H., Toda T., Kimura N., Maruyama N. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J.Neurosci. Res. 2005, 80:120-128.
27. Klareskog L., Padyukov L., Lorentzen J., Alfredsson L. Mechanisms of disease: genetic susceptibility and environmental triggers in the development of rheumatoid arthritis. Nat. Clin. Pract. Rheumatol. 2006, 2:425-433.
28. Klareskog L., Stolt P., Lundberg K., Kallberg H., Bengtsson C., Grunewald J., Ronnelid J., Harris H.E., Ulfgren A.K., Rantapaa-Dahlqvist S., Eklund A., Padyukov L., Alfredsson L. Anew model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum. 2006, 54:38-46.
29. Kochi Y. Genetic background of tolerance breakdown in rheumatoid arthritis. Nihon Rinsho Meneki Gakkai Kaishi 2010, 33:48-56.
30. Kochi Y., Thabet M.M., Suzuki A., Okada Y., Daha N.A., Toes R.E., Huizinga T.W., Myouzen K., Kubo M., Yamada R., Nakamura Y., Yamamoto K. PADI4 polymorphism predisposes male smokers to rheumatoid arthritis. Ann. Rheum. Dis. 2011, 70:512-515.
31. Koike H., Sase K., Uchida H., Sudo T., Shiraiwa M., Sugawara K., Takahara H. Production and epitope specificity of monoclonal antibody against mouse peptidylarginine deiminase type II. Biosci. Biotechnol. Biochem. 1994, 58:2286-2287.
32. (2). Biomed. Environ. Sci. 2010, 23:371-377.
33. Louw C., Gordon A., Johnston N., Mollatt C., Bradley G., Whiteley C.G. Arginine deiminases: therapeutic tools in the etiology and pathogenesis of Alzheimer's disease. J.Enzym. Inhib. Med. Chem. 2007, 22:121-126.
34. Mahdi H., Fisher B.A., Kallberg H., Plant D., Malmstrom V., Ronnelid J., Charles P., Ding B., Alfredsson L., Padyukov L., Symmons D.P., Venables P.J., Klareskog L., Lundberg K. Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis. Nat. Genet. 2009, 41:1319-1324.
35. Mechin M.C., Nachat R., Coudane F., Adoue V., Arnaud J., Serre G., Simon M. Deimination or citrullination, a post-translational modification with many physiological and pathophysiological facets. Med. Sci. (Paris) 2011, 27:49-54.
36. Mettu P.S., Wielgus A.R., Ong S.S., Cousins S.W. Retinal pigment epithelium response to oxidant injury in the pathogenesis of early age-related macular degeneration. Mol. Aspects Med. 2012, 33:376-398.
37. Mohlake P., Whiteley C.G. Arginine metabolising enzymes as therapeutic tools for Alzheimer's disease: peptidyl arginine deiminase catalyses fibrillogenesis of beta-amyloid peptides. Mol. Neurobiol. 2010, 41:149-158.
38. Moscarello M.A., Wood D.D., Ackerley C., Boulias C. Myelin in multiple sclerosis is developmentally immature. J.Clin. Invest. 1994, 94:146-154.
39. Moscarello M.A., Mastronardi F.G., Wood D.D. The role of citrullinated proteins suggests a novel mechanism in the pathogenesis of multiple sclerosis. Neurochem. Res. 2007, 32:251-256.
40. Nakata K., Crabb J.W., Hollyfield J.G. Crystallin distribution in Bruch's membrane-choroid complex from AMD and age-matched donor eyes. Exp. Eye Res. 2005, 80:821-826.
41. Nicholas A.P. Dual immunofluorescence study of citrullinated proteins in Parkinson diseased substantia nigra. Neurosci. Lett. 2011, 495:26-29.
42. Nicholas A.P., Sambandam T., Echols J.D., Barnum S.R. Expression of citrullinated proteins in murine experimental autoimmune encephalomyelitis. J.Comp. Neurol. 2005, 486:254-266.
43. Olsen T.W., Feng X. The Minnesota Grading System of eye bank eyes for age-related macular degeneration. Invest. Ophthalmol. Vis. Sci. 2004, 45:4484-4490.
44. Rudolf M., Clark M.E., Chimento M.F., Li C.M., Medeiros N.E., Curcio C.A. Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy. Invest. Ophthalmol. Vis. Sci. 2008, 49:1200-1209.
45. Seddon J.M., Reynolds R., Yu Y., Daly M.J., Rosner B. Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors. Ophthalmology 2011, 118:2203-2211.
46. Smith W., Assink J., Klein R., Mitchell P., Klaver C.C., Klein B.E., Hofman A., Jensen S., Wang J.J., de Jong P.T. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 2001, 108:697-704.
47. Spraul C.W., Grossniklaus H.E. Characteristics of Drusen and Bruch's membrane in postmortem eyes with age-related macular degeneration. Arch. Ophthalmol. 1997, 115:267-273.
48. Vogt S.D., Curcio C.A., Wang L., Li C.M., McGwin G., Medeiros N.E., Philp N.J., Kimble J.A., Read R.W. Retinal pigment epithelial expression of complement regulator CD46 is altered early in the course of geographic atrophy. Exp. Eye Res. 2011, 93:413-423.
49. Vossenaar E.R., Zendman A.J., van Venrooij W.J., Pruijn G.J. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003, 25:1106-1118.
50. Yamada R., Suzuki A., Chang X., Yamamoto K. Citrullinated proteins in rheumatoid arthritis. Front. Biosci. 2005, 10:54-64.